Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis
Journal of Lipid Research · 2026
DOI: 10.1016/j.jlr.2026.101093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2026. Verfasst von Daniela O Costa und 21 weiteren Autor:innen. Beteiligte Einrichtung: Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK. Electronic address: cos…. Hauptthemen laut MEDLINE: Interleukin-6, Arachidonate 12-Lipoxygenase, Blood Platelets, Blood Coagulation. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation, Academy of Medical Sciences.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is associated with significantly higher thrombotic risk, which is not mechanistically understood. In particular, the detailed mechanisms driving coagulation in arthritis have not been explored, despite the significant impact on patient morbidity and mortality. The role of platelet and blood cell enzymatically oxidized phospholipids (eoxPL) in driving thrombosis and their regulation by inflammation was tested using a mouse model antigen-induced arthritis (AIA) and a human RA cohort. AIA induction significantly elevated plasma thrombin-antithrombin (TAT) complexes, soluble P-selectin (sP-selectin) and serum amyloid A, indicating inflammation and elevated coagulation. Concurrently, platelet-derived eoxPL and their IgG autoantibodies were elevated in whole blood and plasma. These indices were all suppressed by genetic deletion of IL-6Ra, while platelet Alox12 deletion prevented TAT, sP-selectin, and eoxPL/autoantibody increases. Leukocyte Alox15 deletion did not impact circulating TATs or eoxPL. This indicates that IL-6 drives coagulation in AIA via upregulation of platelet Alox12. Conversely, synovial tissue demonstrated raised eoxPL exclusively from Alox15. In human RA, immunoreactivity towards platelet-derived eoxPL was elevated in early disease. Thus, while both LOX isoforms differentially contribute to AIA in mice, only Alox12 promotes thrombosis risk, while evidence for increased eoxPL exposure in early human RA was revealed. In summary, the IL-6/Alox12 axis drives platelet activation in AIA, providing a potential mechanistic explanation for recent clinical trial data proposing that anti-iL-6 therapy is associated with reduced coagulation in early RA. The procoagulant lipid membrane is proposed as a therapeutic target for preventing vascular events in autoimmune disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK. Electronic address: costad2@cardiff.ac.uk.
- Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
- Haematology Department, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
Förderung
- Wellcome Trust
- British Heart Foundation
- Academy of Medical Sciences
- Kuwait University
- Horizon 2020 Marie Skłodowska-Curie Actions
- Welsh Government
- UK Research and Innovation Medical Research Council
Zitieren
APA
Costa, D. O., Hughes, S. T. O., Jenkins, R. H., Figueras, A. C., Protty, M. B., Tyrrell, V. J., Hajeyah, A. A., Jones, G. W., Burston, J. J., Morgan, B., Monaco, F., Hill, D., Morrin, A. S., Guy, C., Bacon, A., Giera, M., Toes, R. E. M., Jenkins, P. V., Collins, P. W., …, & O'Donnell, V. B. (2026). Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2026.101093
Vancouver
Costa DO, Hughes STO, Jenkins RH, Figueras AC, Protty MB, Tyrrell VJ, et al. Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis. Journal of Lipid Research. 2026. doi:10.1016/j.jlr.2026.101093
BibTeX
@article{Costa2026,
author = {Costa, Daniela O and Hughes, Stuart T O and Jenkins, Robert H and Figueras, Ana Cardus and Protty, Majd B and Tyrrell, Victoria J and Hajeyah, Ali A and Jones, Gareth W and Burston, James J and Morgan, Bethan and Monaco, Federica and Hill, David and Morrin, Aisling S and Guy, Carol and Bacon, Alice and Giera, Martin and Toes, Rene E M and Jenkins, P Vince and Collins, Peter W and Choy, Ernest and Jones, Simon A and O'Donnell, Valerie B},
title = {Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis},
journal = {Journal of Lipid Research},
year = {2026},
doi = {10.1016/j.jlr.2026.101093}
}
EUVIMED